Abstract
Current Alzheimer Research
Title: Commentary (Complement-Initiated Neuroinflammation and Its Role in Early Stage Alzheimers Disease)
Volume: 8 Issue: 1
Author(s): Girish J. Kotwal
Affiliation:
Keywords: E-4 Allele, Neuroinflammattion, CNS Inflammation, Inflammatory damage, Pathogenesis, Astrocytes, Alpha-beta aggregates, c5a receptor, Therapeutic Intervention, Prognostic Markers, Proinflammatory cytokinesis, Proinflammatory chemotactic factors
Abstract: Full text available.
Export Options
About this article
Cite this article as:
J. Kotwal Girish, Commentary (Complement-Initiated Neuroinflammation and Its Role in Early Stage Alzheimers Disease), Current Alzheimer Research 2011; 8 (1) . https://dx.doi.org/10.2174/156720511794604615
DOI https://dx.doi.org/10.2174/156720511794604615 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Impact of Introducing Catheter-based Renal Denervation into Japan for Hypertension Management: Estimation of Number of Target Patients and Clinical Relevance of Ambulatory Blood Pressure Reduction
Current Hypertension Reviews New Proposals for Treatment Sporadic Alzheimers Disease
Central Nervous System Agents in Medicinal Chemistry An Overview of Interleukin-1 Receptor Antagonist, Anakinra, in the Treatment of Cutaneous Diseases
Current Clinical Pharmacology Therapeutic Targets in the Ubiquitin-proteasome System for Alzheimer's Disease
Current Enzyme Inhibition Extracellular Superoxide Dismutase (EC-SOD) Quenches Free Radicals and Attenuates Age-Related Cognitive Decline: Opportunities for Novel Drug Development in Aging
Current Alzheimer Research Advances in Neuroimaging for HIV-1 Associated Neurological Dysfunction: Clues to the Diagnosis, Pathogenesis and Therapeutic Monitoring
Current HIV Research New Directions for Dementia
Current Neurovascular Research Sensory-Motor Integration in the Medial Medulla
Current Neuropharmacology Targeting Host Store-Operated Ca<sup>2+</sup> Release to Attenuate Viral Infections
Current Topics in Medicinal Chemistry Bioinformatics Approach to BDNF and BDNF-Related Disorders
Current Neuropharmacology Drugs as Possible Triggers of Takotsubo Cardiomyopathy: A Comprehensive Literature Search - Update 2015
Current Clinical Pharmacology Cholinesterase Inhibitory Activities of N-Phenylthiazol-2-Amine Derivatives and their Molecular Docking Studies
Medicinal Chemistry Diagnostic and Therapeutic Nanoparticles in Cardiovascular Diseases
Current Pharmaceutical Design α7-Nicotinic Receptors and Cognition
Current Drug Targets On the Paradigm Shift Towards Multitarget Selective Drug Design
Current Computer-Aided Drug Design From Alpha to Omega with Aβ: Targeting the Multiple Molecular Appearances of the Pathogenic Peptide in Alzheimers Disease
Current Medicinal Chemistry Systems Biology Approaches and Metabolomics for Understanding Japanese Traditional Kampo Medicine
Current Pharmacogenomics and Personalized Medicine Intracerebral Hemorrhage and Diabetes Mellitus: Blood-Brain Barrier Disruption, Pathophysiology and Cognitive Impairments
CNS & Neurological Disorders - Drug Targets Phosphatidylserine and Curcumin Act Synergistically to Down-Regulate Release of Interleukin-1β from Lipopolysaccharide-Stimulated Cortical Primary Microglial Cells
CNS & Neurological Disorders - Drug Targets Recent Progress of Imaging Agents for Parkinson’s Disease
Current Neuropharmacology